• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods . Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: a feasible alternative approach with low technical requirements

tetano

Editor, Senior Moderator
J Virol Methods


. 2021 Feb 9;291:114086.
doi: 10.1016/j.jviromet.2021.114086. Online ahead of print.
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: a feasible alternative approach with low technical requirements


Benoit Visseaux[SUP] 1 [/SUP], Gilles Collin[SUP] 1 [/SUP], Nadhira Houhou-Fidouh[SUP] 1 [/SUP], Quentin Le Hingrat[SUP] 1 [/SUP], Valentine Marie Ferr?[SUP] 1 [/SUP], Florence Damond[SUP] 1 [/SUP], Houria Ichou[SUP] 1 [/SUP], Diane Descamps[SUP] 1 [/SUP], Charlotte Charpentier[SUP] 2 [/SUP]



Affiliations
Free PMC article

Abstract

The worldwide demand for SARS-CoV-2 RT-PCR testing resulted in a shortage of diagnostic kits. RNA extraction step constitutes a major bottleneck to perform diagnostic. The aim of this study was to assess performances of different extraction-free SARS-CoV-2 RT-PCR assays compared to a reference RT-PCR assay. The panel of evaluation consisted of 94 samples: 69 positive and 25 negative for SARS-CoV-2 by reference RT-PCR. Three extraction-free RT-PCR assays were assessed: (i) PrimeDirect? Probe RT-qPCR Mix (Takara), (ii) PrimeScript?RT-PCR (Takara), and (iii) SARS-CoV-2 SANSURE?BIOTECH Novel Coronavirus (Sansure). The overall sensitivity of PrimeDirect, PrimeScript and Sansure assays was 55.1%, 69.6% and 69.6%, respectively. The sensitivity increased among samples with Ct<30: 91.9% (n = 34/37), 89.2% (n = 33/37) and 94.6% (n = 35/37) for PrimeDirect, PrimeScript and Sansure assays, respectively. The specificity was 88%, 100% and 100% for PrimeDirect, PrimeScript and Sansure assays, respectively. In the present study, we showed a good sensitivity of extraction-free PCR assays, especially for high viral loads (Ct<30), except PrimeDirect that displayed imperfect sensitivity and specificity. Despite a lower sensitivity for low viral loads, extraction-free reagents can provide a valuable option, cheaper, easier and less reagent consuming for SARS-CoV-2 diagnostic, especially in laboratory with lower experience and equipment for molecular assays.

Keywords: RT-PCR; SARS-CoV-2; extraction-free.
 
Back
Top Bottom